Filana Therapeutics (FLNA) EBIT Margin (2010 - 2026)
Filana Therapeutics' EBIT Margin came in at 93.36% for Q4 2013, up 167.91 percentage points from -74.55% a year earlier and up 132.99 percentage points from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) EBIT Margin (2010 - 2026) Analysis & Trends
For FY2013, Filana Therapeutics' EBIT Margin was 76.28%, up 112.06 percentage points from FY2012.
- EBIT Margin carries a four-year change of +109.12 percentage points (FY2009 to FY2013).
- Going back by year, EBIT Margin was -35.79% in FY2012 (-5.19 pp), -30.60% in FY2011 (+50.92 pp), -81.52% in FY2010 (-48.68 pp) and -32.85% in FY2009.
- The Q4 2013 figure represents the highest quarterly EBIT Margin in data going back to Q2 2010.
- Year-over-year, EBIT Margin increased in four of the last eight quarters, with an average year-over-year change of +17.50 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2013 (a gain of 167.91 percentage points), and the weakest in Q4 2012 (a drop of 53.29 percentage points).
- Business Quant data shows FLNA's EBIT Margin at -39.63% (Q3 2013), -16.28% (Q2 2013) and -22.63% (Q1 2013) in the three quarters before Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.83 Bn | 1,107.41 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 618.88 Bn | 537.41 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 502.93 Bn | 476.04 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 369.61 Bn | 323.99 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.70 Bn | 262.69 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.59 Bn | 192.99 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.60 Bn | 165.79 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.23 Bn | 116.88 Bn | 10.94 Bn | 28.37% |
| 10 | Filana Therapeutics | 31.75 Mn | -339.09 Mn | - | -1,257.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,257.43% |
| Mar 31, 2026 | -1,415.46% |
| Dec 31, 2025 | -1,391.38% |
| Sep 30, 2025 | -1,016.28% |
| Jun 30, 2025 | -3,739.04% |
| Mar 31, 2025 | -1,943.56% |
| Dec 31, 2024 | -1,638.17% |
| Sep 30, 2024 | -1,169.71% |
| Jun 30, 2024 | -2,651.21% |
| Mar 31, 2024 | -1,122.41% |
| Dec 31, 2023 | -1,443.26% |
| Sep 30, 2023 | -1,390.47% |
| Jun 30, 2023 | -1,309.24% |
| Mar 31, 2023 | -1,292.64% |
| Dec 31, 2022 | -1,347.30% |
| Sep 30, 2022 | -2,431.09% |
| Dec 31, 2013 | 93.36% |
| Sep 30, 2013 | -39.63% |
| Jun 30, 2013 | -16.28% |
| Mar 31, 2013 | -22.63% |
API Access
Filana Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();